Herpes Zoster Vaccine & Cardiovascular Risk – Vax-Before-Travel
- As of August 29, 2025, several studies have indicated a possible association between the herpes zoster vaccine and an elevated risk of stroke. The findings, detailed...
- The media release emphasizes that "Further research studies are now needed to find out weather this association can be attributed to an affect of herpes zoster...
- An assessment of these risk factors and prevention strategies was scheduled to be presented at the European Society of Cardiology (ESC) Congress on August 30, 2025.
Shingles Vaccine and Stroke Risk: An Ongoing Investigation
Initial Research Suggests Possible Link
As of August 29, 2025, several studies have indicated a possible association between the herpes zoster vaccine and an elevated risk of stroke. The findings, detailed in a media release, highlight the need for further investigation to determine if the vaccine directly contributes to this increased risk.
Further Research Needed to Confirm Causal Relationship
The media release emphasizes that “Further research studies are now needed to find out weather this association can be attributed to an affect of herpes zoster vaccination.” This suggests that while a correlation has been observed, a direct causal link has not yet been established.
An assessment of these risk factors and prevention strategies was scheduled to be presented at the European Society of Cardiology (ESC) Congress on August 30, 2025.
Shingles Vaccination Readily Available
On August 29, 2025, shingles vaccination services,such as Shingrix,were widely accessible at pharmacies and clinics throughout the United States and the United Kingdom. This widespread availability underscores the importance of understanding the potential risks and benefits associated wiht the vaccine.